Luke Zheng

8PUBLICATIONS
31CO-AUTHORS
Clinical chemistry (incl. diagnostics)Respiratory diseasesCardiology (incl. cardiovascular diseases)Predictive and prognostic markersOther biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 29, 2025
Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients.

Natasha J Burke, Lisa M Mendelson, Tracy Joshi

|Jul 14, 2023
Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.

Kamil F Faridi, Jordan B Strom, Harun Kundi

|Jun 03, 2022
Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.

Aliza Hussain, Salim S Virani, Luke Zheng

|Aug 05, 2021
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.

Andrew Staron, Luke Zheng, Gheorghe Doros

|Nov 11, 2020
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities.

Andrew Staron, Lawreen H Connors, Luke Zheng

|Sep 03, 2020
Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis.

Shayna Sarosiek, Luke Zheng, J Mark Sloan

Pageof 2

Frequent Collaborators

5 joint publications

Vaishali Sanchorawala

4 joint publications

Andrew Staron

3 joint publications

Gheorghe Doros

2 joint publications

Lawreen H Connors